EGFR and cancer: Our results demonstrated that the exclusive miRNAs in HBER AMP-Cell are predicted to regulate pathways such as the glucagon, insulin and oxytocin signaling pathways, while the upregulated miRNAs in HBER AMP-Cell are predicted to be involved in proteoglycans in cancer and ErbB and VEGF signaling pathways.